New obesity drug MKP10241 enters human testing – food may change how it works
NCT ID NCT07098663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called MKP10241 in healthy people, people with obesity, and those with obesity plus type 2 diabetes. Researchers want to see if taking the drug with food changes how it works, and whether different doses are safe. About 68 participants will take either the drug or a placebo and be closely monitored for side effects. This is an early-phase study focused on safety and drug behavior, not on curing or treating the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOOD EFFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veritus Research
RECRUITINGBayswater, Victoria, 3153, Australia
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?